Abciximab
Ibuprofen may increase the anticoagulant activities of Abciximab.
Abiraterone
The serum concentration of Ibuprofen can be increased when it is combined with Abiraterone.
Acebutolol
Ibuprofen may decrease the antihypertensive activities of Acebutolol.
Advertisement
Aceclofenac
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Aceclofenac.
Acemetacin
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Acemetacin.
Acenocoumarol
Ibuprofen may increase the anticoagulant activities of Acenocoumarol.
Advertisement
Acetyl salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.
Aclarubicin
Ibuprofen may decrease the excretion rate of Aclarubicin which could result in a higher serum level.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Ibuprofen.
Advertisement
Alclometasone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alclometasone.
Aldosterone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Aldosterone.
Alendronate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.
Alendronic acid
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.
Aliskiren
Ibuprofen may decrease the antihypertensive activities of Aliskiren.
Alminoprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alminoprofen.
Alprenolol
Ibuprofen may decrease the antihypertensive activities of Alprenolol.
Alprostadil
The therapeutic efficacy of Alprostadil can be decreased when used in combination with Ibuprofen.
Amcinonide
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Amcinonide.
Amikacin
Ibuprofen may decrease the excretion rate of Amikacin which could result in a higher serum level.
Amiloride
Ibuprofen may decrease the antihypertensive activities of Amiloride.
Amiodarone
The metabolism of Ibuprofen can be decreased when combined with Amiodarone.
Ancrod
Ibuprofen may increase the anticoagulant activities of Ancrod.
Androstenedione
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Androstenedione.
Anhydrous Tacrolimus
Ibuprofen may increase the nephrotoxic activities of Tacrolimus.
Antipyrine
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Antipyrine.
Antithrombin III
Ibuprofen may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Ibuprofen may increase the anticoagulant activities of Antithrombin III human.
Apalutamide
The serum concentration of Ibuprofen can be decreased when it is combined with Apalutamide.
Apazone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Azapropazone.
Apixaban
Ibuprofen may increase the anticoagulant activities of Apixaban.
Apremilast
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Apremilast.
Aprepitant
The metabolism of Ibuprofen can be increased when combined with Aprepitant.
Arbekacin
Ibuprofen may decrease the excretion rate of Arbekacin which could result in a higher serum level.
Ardeparin
Ibuprofen may increase the anticoagulant activities of Ardeparin.
Argatroban
Ibuprofen may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Ibuprofen may increase the anticoagulant activities of Argatroban.
Armodafinil
The metabolism of Ibuprofen can be decreased when combined with Armodafinil.
Aspirin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.
Atenolol
Ibuprofen may decrease the antihypertensive activities of Atenolol.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Ibuprofen.
azficel-T
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Azficel-T.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Ibuprofen.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Ibuprofen.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Ibuprofen.
Azosemide
The therapeutic efficacy of Azosemide can be decreased when used in combination with Ibuprofen.
Balsalazide
Ibuprofen may increase the nephrotoxic activities of Balsalazide.
Becaplermin
Ibuprofen may increase the anticoagulant activities of Becaplermin.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Beclomethasone dipropionate.
Benazepril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Benazepril.
Bendroflumethiazide
The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Ibuprofen.
Benzydamine
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Benzydamine.
Betamethasone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Betamethasone.
Betaxolol
Ibuprofen may decrease the antihypertensive activities of Betaxolol.
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Ibuprofen.
Bimatoprost
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Ibuprofen.
Bisoprolol
Ibuprofen may decrease the antihypertensive activities of Bisoprolol.
Bivalirudin
Ibuprofen may increase the anticoagulant activities of Bivalirudin.
Bopindolol
Ibuprofen may decrease the antihypertensive activities of Bopindolol.
Bortezomib
The metabolism of Ibuprofen can be decreased when combined with Bortezomib.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Ibuprofen.
Budesonide
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Budesonide.
Bufexamac
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Bufexamac.
Bumetanide
The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuprofen.
Bupranolol
Ibuprofen may decrease the antihypertensive activities of Bupranolol.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Ibuprofen.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Ibuprofen.
Capecitabine
The metabolism of Ibuprofen can be decreased when combined with Capecitabine.
Captopril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Captopril.
Carbamazepine
The metabolism of Ibuprofen can be increased when combined with Carbamazepine.
Carboprost
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Ibuprofen.
Carboprost Tromethamine
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Ibuprofen.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Ibuprofen.
Carteolol
Ibuprofen may decrease the antihypertensive activities of Carteolol.
Carvedilol
Ibuprofen may decrease the antihypertensive activities of Carvedilol.
Celecoxib
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Celecoxib.
Celiprolol
Ibuprofen may decrease the antihypertensive activities of Celiprolol.
Ceritinib
The serum concentration of Ibuprofen can be increased when it is combined with Ceritinib.
Certoparin
Ibuprofen may increase the anticoagulant activities of Certoparin.
Chloramphenicol
The metabolism of Ibuprofen can be decreased when combined with Chloramphenicol.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Ibuprofen.
Chlorothiazide
The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Ibuprofen.
Chlorthalidone
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Ibuprofen.
Cholecalciferol
The metabolism of Ibuprofen can be decreased when combined with Cholecalciferol.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Ibuprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Choline magnesium trisalicylate.
Ciclesonide
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Ciclesonide.
Cilazapril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Cilazapril.
Cimetidine
The metabolism of Ibuprofen can be decreased when combined with Cimetidine.
Cinoxacin
Ibuprofen may increase the neuroexcitatory activities of Cinoxacin.
Citalopram
The metabolism of Ibuprofen can be decreased when combined with Citalopram.
Citric Acid
Ibuprofen may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Ibuprofen may increase the anticoagulant activities of Citric Acid.
Clobetasol
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Clobetasol.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Clobetasol propionate.
Clobetasone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Clobetasone.
Clocortolone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Clocortolone.
Clodronic Acid
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Clodronic Acid.
Clofezone
The metabolism of Ibuprofen can be decreased when combined with Rabeprazole.
Clonixin
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Clonixin.
Clotrimazole
The metabolism of Ibuprofen can be decreased when combined with Clotrimazole.
Colesevelam
Colesevelam can cause a decrease in the absorption of Ibuprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Ibuprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Cortisone acetate.
Crisaborole
The metabolism of Ibuprofen can be decreased when combined with Crisaborole.
Curcumin
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Curcumin.
Cyclopenthiazide
The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Ibuprofen.
Cyclosporine
Ibuprofen may increase the nephrotoxic activities of Cyclosporine.
Dabigatran Etexilate
Ibuprofen may increase the anticoagulant activities of Dabigatran etexilate.
Dabrafenib
The serum concentration of Ibuprofen can be decreased when it is combined with Dabrafenib.
Dalteparin
Ibuprofen may increase the anticoagulant activities of Dalteparin.
Danaparoid
Ibuprofen may increase the anticoagulant activities of Danaparoid.
Daunorubicin
Ibuprofen may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Deferasirox
The serum concentration of Ibuprofen can be increased when it is combined with Deferasirox.
Deflazacort
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Deflazacort.
Delavirdine
The metabolism of Ibuprofen can be decreased when combined with Delavirdine.
Desirudin
Ibuprofen may increase the anticoagulant activities of Desirudin.
Desmopressin
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Desmopressin.
Desonide
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Desonide.
Desoximetasone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Desoximetasone.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Desoxycorticosterone acetate.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Desoxycorticosterone Pivalate.
Dexamethasone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Dexamethasone.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Ibuprofen.
Dextran
Ibuprofen may increase the anticoagulant activities of Dextran.
Dextran 40
Ibuprofen may increase the anticoagulant activities of Dextran 40.
Dextran 70
Ibuprofen may increase the anticoagulant activities of Dextran 70.
Dextran 75
Ibuprofen may increase the anticoagulant activities of Dextran 75.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Ibuprofen.
Dicumarol
Ibuprofen may increase the anticoagulant activities of Dicoumarol.
Diflorasone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Diflorasone.
Diflucortolone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Difluocortolone.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Ibuprofen.
Difluprednate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Difluprednate.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Ibuprofen.
Dihydrostreptomycin
Ibuprofen may decrease the excretion rate of Dihydrostreptomycin which could result in a higher serum level.
Dinoprost
The therapeutic efficacy of Dinoprost can be decreased when used in combination with Ibuprofen.
Dinoprost Tromethamine
The therapeutic efficacy of Dinoprost Tromethamine can be decreased when used in combination with Ibuprofen.
Dinoprostone
The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Ibuprofen.
Dipyrone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Metamizole.
Dothiepin
The metabolism of Ibuprofen can be decreased when combined with Dosulepin.
Doxorubicin
Ibuprofen may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Doxorubicin Hydrochloride
Ibuprofen may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Drospirenone
Ibuprofen may increase the hyperkalemic activities of Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Droxicam.
Edetic Acid
Ibuprofen may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Ibuprofen may increase the anticoagulant activities of Edoxaban.
Efavirenz
The metabolism of Ibuprofen can be decreased when combined with Efavirenz.
Enalapril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Enalaprilat.
Enoxacin
Ibuprofen may increase the neuroexcitatory activities of Enoxacin.
Enoxaparin
Ibuprofen may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Ibuprofen may increase the anticoagulant activities of Enoxaparin.
Epirubicin
Ibuprofen may decrease the excretion rate of Epirubicin which could result in a higher serum level.
Eplerenone
Ibuprofen may decrease the antihypertensive activities of Eplerenone.
Epoprostenol
The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Ibuprofen.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Ibuprofen.
Eslicarbazepine Acetate
The metabolism of Ibuprofen can be decreased when combined with Eslicarbazepine acetate.
Esmolol
Ibuprofen may decrease the antihypertensive activities of Esmolol.
Esomeprazole
The metabolism of Ibuprofen can be decreased when combined with Esomeprazole.
Estrone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Ibuprofen.
Ethacrynate
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Ibuprofen.
Ethacrynic Acid
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Ibuprofen.
Ethylenediaminetetraacetate
Ibuprofen may increase the anticoagulant activities of Edetic Acid.
Etidronate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Etidronic acid.
Etidronic Acid
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Etidronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Etodolac.
Etofenamate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Etofenamate.
Etoricoxib
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Etoricoxib.
Etravirine
The metabolism of Ibuprofen can be decreased when combined with Etravirine.
Evening primrose oil
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Evening primrose oil.
Felbinac
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Felbinac.
Felodipine
The metabolism of Ibuprofen can be decreased when combined with Felodipine.
Fenbufen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fenbufen.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Ibuprofen.
Ferulic Acid
Ibuprofen may increase the anticoagulant activities of Ferulic acid.
Fleroxacin
Ibuprofen may increase the neuroexcitatory activities of Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Ibuprofen.
Floxuridine
The metabolism of Ibuprofen can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Ibuprofen can be decreased when combined with Fluconazole.
Fludrocortisone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fludrocortisone.
Fluindione
Ibuprofen may increase the anticoagulant activities of Fluindione.
Flumequine
Ibuprofen may increase the neuroexcitatory activities of Flumequine.
Flumethasone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Flumethasone.
Flunisolide
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Flunisolide.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Flunisolide.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluocinolone Acetonide.
Fluocinonide
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluocinonide.
Fluocortolone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluocortolone.
Fluorometholone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluorometholone.
Fluorouracil
The metabolism of Ibuprofen can be decreased when combined with Fluorouracil.
Fluoxetine
The metabolism of Ibuprofen can be decreased when combined with Fluoxetine.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluprednidene.
Fluprednisolone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluprednisolone.
Flurandrenolide
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Flurandrenolide.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Ibuprofen.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluticasone furoate.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluticasone propionate.
Fluvastatin
The metabolism of Ibuprofen can be decreased when combined with Fluvastatin.
Fluvoxamine
The metabolism of Ibuprofen can be decreased when combined with Fluvoxamine.
Folate
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Ibuprofen.
Folic Acid
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Ibuprofen.
Fondaparinux
Ibuprofen may increase the anticoagulant activities of Fondaparinux.
Fondaparinux sodium
Ibuprofen may increase the anticoagulant activities of Fondaparinux sodium.
Formestane
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Formestane.
Fosinopril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fosinopril.
Fosphenytoin
The metabolism of Ibuprofen can be increased when combined with Fosphenytoin.
Framycetin
Ibuprofen may decrease the excretion rate of Framycetin which could result in a higher serum level.
Furosemide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.
Gatifloxacin
Ibuprofen may increase the neuroexcitatory activities of Gatifloxacin.
Gatifloxacin Anhydrous
Ibuprofen may increase the neuroexcitatory activities of Gatifloxacin.
Gemeprost
The therapeutic efficacy of Gemeprost can be decreased when used in combination with Ibuprofen.
Gemfibrozil
The metabolism of Ibuprofen can be decreased when combined with Gemfibrozil.
Gemifloxacin
Ibuprofen may increase the neuroexcitatory activities of Gemifloxacin.
Gemifloxacin Mesylate
Ibuprofen may increase the neuroexcitatory activities of Gemifloxacin.
Gentamicin
Ibuprofen may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Grepafloxacin
Ibuprofen may increase the neuroexcitatory activities of Grepafloxacin.
Halcinonide
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Halcinonide.
Halobetasol
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Ulobetasol.
Haloperidol
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Haloperidol.
Heparin
Ibuprofen may increase the anticoagulant activities of Heparin.
Hydralazine
Ibuprofen may decrease the antihypertensive activities of Hydralazine.
Hydrochlorothiazide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Ibuprofen.
Hydrocortisone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Ibuprofen.
Ibandronate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Ibandronate.
Ibandronic Acid
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Ibandronate.
Icatibant
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Icatibant.
Idarubicin
Ibuprofen may decrease the excretion rate of Idarubicin which could result in a higher serum level.
Iloprost
The therapeutic efficacy of Iloprost can be decreased when used in combination with Ibuprofen.
Imatinib
The serum concentration of Imatinib can be decreased when it is combined with Ibuprofen.
Imidapril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Imidapril.
Indapamide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Ibuprofen.
Indinavir
The metabolism of Ibuprofen can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Ibuprofen can be decreased when combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Indobufen.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Ibuprofen.
Irbesartan
The metabolism of Ibuprofen can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Ibuprofen can be increased when it is combined with Isavuconazole.
Isoniazid
The metabolism of Ibuprofen can be decreased when combined with Isoniazid.
Kanamycin
Ibuprofen may decrease the excretion rate of Kanamycin which could result in a higher serum level.
kanamycin A
Ibuprofen may decrease the excretion rate of Kanamycin which could result in a higher serum level.
Kebuzone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Kebuzone.
Ketoconazole
The metabolism of Ibuprofen can be decreased when combined with Ketoconazole.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Ibuprofen.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Ibuprofen.
Labetalol
Ibuprofen may decrease the antihypertensive activities of Labetalol.
Lapatinib
The metabolism of Ibuprofen can be decreased when combined with Lapatinib.
Latanoprost
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Ibuprofen.
Latanoprostene Bunod
The therapeutic efficacy of Latanoprostene Bunod can be decreased when used in combination with Ibuprofen.
Leflunomide
The metabolism of Ibuprofen can be decreased when combined with Leflunomide.
Lepirudin
Ibuprofen may increase the anticoagulant activities of Lepirudin.
Levobunolol
Ibuprofen may decrease the antihypertensive activities of Levobunolol.
Levofloxacin
Ibuprofen may increase the neuroexcitatory activities of Levofloxacin.
Levofloxacin Anhydrous
Ibuprofen may increase the neuroexcitatory activities of Levofloxacin.
Limonene, (+)-
The risk or severity of adverse effects can be increased when Ibuprofen is combined with (4R)-limonene.
Lisinopril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Lisinopril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Ibuprofen.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Ibuprofen.
Lopinavir
The metabolism of Ibuprofen can be increased when combined with Lopinavir.
Lornoxicam
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Lornoxicam.
Losartan
The metabolism of Ibuprofen can be decreased when combined with Losartan.
Loteprednol
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Loteprednol.
Lovastatin
The metabolism of Ibuprofen can be decreased when combined with Lovastatin.
Loxoprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Loxoprofen.
Lubiprostone
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Ibuprofen.
Luliconazole
The serum concentration of Ibuprofen can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Ibuprofen can be increased when it is combined with Lumacaftor.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Magnesium salicylate.
Manidipine
The metabolism of Ibuprofen can be decreased when combined with Manidipine.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Ibuprofen.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ibuprofen.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ibuprofen.
Medronate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Technetium Tc-99m medronate.
Medrysone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Medrysone.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Ibuprofen.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Ibuprofen.
Mesalamine
Ibuprofen may increase the nephrotoxic activities of Mesalazine.
Methotrexate
The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.
Methyclothiazide
The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Ibuprofen.
Methylprednisolone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Methylprednisolone.
Metipranolol
Ibuprofen may decrease the antihypertensive activities of Metipranolol.
Metolazone
The therapeutic efficacy of Metolazone can be decreased when used in combination with Ibuprofen.
Metoprolol
Ibuprofen may decrease the antihypertensive activities of Metoprolol.
Metrizamide
Ibuprofen may decrease the excretion rate of Metrizamide which could result in a higher serum level.
Midostaurin
The metabolism of Ibuprofen can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Ibuprofen can be increased when it is combined with Mifepristone.
Misoprostol
The therapeutic efficacy of Misoprostol can be decreased when used in combination with Ibuprofen.
Moclobemide
The metabolism of Ibuprofen can be decreased when combined with Moclobemide.
Modafinil
The metabolism of Ibuprofen can be decreased when combined with Modafinil.
Moexipril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Moexipril.
Mometasone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Mometasone.
Morniflumate
The risk or severity of adverse effects can be increased when Morniflumate is combined with Ibuprofen.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Ibuprofen.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Ibuprofen.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Ibuprofen.
Nabumetone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Nabumetone.
Nadolol
Ibuprofen may decrease the antihypertensive activities of Nadolol.
Nadroparin
Ibuprofen may increase the anticoagulant activities of Nadroparin.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Ibuprofen.
Nalidixic Acid
Ibuprofen may increase the neuroexcitatory activities of Nalidixic Acid.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Ibuprofen.
Nebivolol
Ibuprofen may decrease the antihypertensive activities of Nebivolol.
Nelfinavir
The metabolism of Ibuprofen can be decreased when combined with Nelfinavir.
Neomycin
Ibuprofen may decrease the excretion rate of Neomycin which could result in a higher serum level.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Ibuprofen.
Netilmicin
Ibuprofen may decrease the excretion rate of Netilmicin which could result in a higher serum level.
Nicardipine
The metabolism of Ibuprofen can be decreased when combined with Nicardipine.
Niflumic Acid
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Niflumic Acid.
Nilotinib
The metabolism of Ibuprofen can be decreased when combined with Nilotinib.
Nimesulide
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Nimesulide.
Norfloxacin
Ibuprofen may increase the neuroexcitatory activities of Norfloxacin.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Evening primrose oil.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Ibuprofen.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Ibuprofen.
Olsalazine
Ibuprofen may increase the nephrotoxic activities of Olsalazine.
Omacetaxine Mepesuccinate
The risk or severity of bleeding can be increased when Ibuprofen is combined with Omacetaxine mepesuccinate.
Omeprazole
The metabolism of Ibuprofen can be decreased when combined with Omeprazole.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Ibuprofen.
Oxprenolol
Ibuprofen may decrease the antihypertensive activities of Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Oxyphenbutazone.
Pamidronate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Pamidronate.
Pamidronic Acid
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Pamidronate.
Pantoprazole
The metabolism of Ibuprofen can be decreased when combined with Pantoprazole.
Paramethasone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Paramethasone.
Parecoxib
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Parecoxib.
Paromomycin
Ibuprofen may decrease the excretion rate of Paromomycin which could result in a higher serum level.
Parthenolide
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Parthenolide.
Pefloxacin
Ibuprofen may increase the neuroexcitatory activities of Pefloxacin.
Penbutolol
Ibuprofen may decrease the antihypertensive activities of Penbutolol.
Pentaerythritol Tetranitrate
Ibuprofen may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentosan Polysulfate
Ibuprofen may increase the anticoagulant activities of Pentosan Polysulfate.
Perindopril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Perindopril.
Phenindione
Ibuprofen may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Ibuprofen can be increased when combined with Phenobarbital.
Phenprocoumon
Ibuprofen may increase the anticoagulant activities of Phenprocoumon.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Ibuprofen.
Phenytoin
The metabolism of Ibuprofen can be increased when combined with Phenytoin.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ibuprofen.
Pindolol
Ibuprofen may decrease the antihypertensive activities of Pindolol.
Pioglitazone
The metabolism of Ibuprofen can be decreased when combined with Pioglitazone.
Pirarubicin
Ibuprofen may decrease the excretion rate of Pirarubicin which could result in a higher serum level.
Piretanide
The therapeutic efficacy of Piretanide can be decreased when used in combination with Ibuprofen.
Pirfenidone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Pirfenidone.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Ibuprofen.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Ibuprofen.
Plicamycin
Ibuprofen may decrease the excretion rate of Plicamycin which could result in a higher serum level.
Polythiazide
The therapeutic efficacy of Polythiazide can be decreased when used in combination with Ibuprofen.
Practolol
Ibuprofen may decrease the antihypertensive activities of Practolol.
Pralatrexate
The serum concentration of Pralatrexate can be increased when it is combined with Ibuprofen.
Prasterone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Prasterone.
Prednicarbate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Prednicarbate.
Prednisolone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Prednisolone.
Prednisone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Prednisone.
Pregnenolone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Pregnenolone.
Primidone
The metabolism of Ibuprofen can be increased when combined with Primidone.
Probenecid
The serum concentration of Ibuprofen can be increased when it is combined with Probenecid.
Propranolol
Ibuprofen may decrease the antihypertensive activities of Propranolol.
protein C, human
Ibuprofen may increase the anticoagulant activities of Protein C.
protein S, human
Ibuprofen may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Ibuprofen may increase the anticoagulant activities of Protocatechualdehyde.
Pyrimethamine
The metabolism of Ibuprofen can be decreased when combined with Pyrimethamine.
Quinapril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Quinapril.
Quinethazone
The therapeutic efficacy of Quinethazone can be decreased when used in combination with Ibuprofen.
Quinine
The metabolism of Ibuprofen can be decreased when combined with Quinine.
Rabeprazole
The metabolism of Ibuprofen can be decreased when combined with Rabeprazole.
Ramipril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Ramipril.
Ranolazine
The serum concentration of Ibuprofen can be increased when it is combined with Ranolazine.
Rescinnamine
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Rescinnamine.
Resveratrol
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Resveratrol.
Reviparin
Ibuprofen may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Ibuprofen may increase the anticoagulant activities of Reviparin.
Rifampin
The metabolism of Ibuprofen can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Ibuprofen can be increased when combined with Rifapentine.
Rimexolone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Rimexolone.
Risedronate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Risedronate.
Risedronic Acid
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Risedronate.
Rivaroxaban
Ibuprofen may increase the anticoagulant activities of Rivaroxaban.
Rofecoxib
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Rofecoxib.
Rosiglitazone
The metabolism of Ibuprofen can be decreased when combined with Rosiglitazone.
Rosoxacin
Ibuprofen may increase the neuroexcitatory activities of Rosoxacin.
Rucaparib
The metabolism of Ibuprofen can be decreased when combined with Rucaparib.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Ibuprofen.
Salicylamide
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Salicylamide.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Ibuprofen.
Salsalate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Salsalate.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Ibuprofen.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Ibuprofen.
Secobarbital
The metabolism of Ibuprofen can be increased when combined with Secobarbital.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Serrapeptase.
Sertraline
The metabolism of Ibuprofen can be decreased when combined with Sertraline.
Sildenafil
The metabolism of Ibuprofen can be decreased when combined with Sildenafil.
Sisomicin
Ibuprofen may decrease the excretion rate of Sisomicin which could result in a higher serum level.
Sodium Phosphate
Sodium phosphate may increase the nephrotoxic activities of Ibuprofen.
Sodium Phosphate, Monobasic
Sodium phosphate may increase the nephrotoxic activities of Ibuprofen.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Sodium phosphate may increase the nephrotoxic activities of Ibuprofen.
Sorafenib
The metabolism of Ibuprofen can be decreased when combined with Sorafenib.
Sotalol
Ibuprofen may decrease the antihypertensive activities of Sotalol.
Sparfloxacin
Ibuprofen may increase the neuroexcitatory activities of Sparfloxacin.
Spectinomycin
Ibuprofen may decrease the excretion rate of Spectinomycin which could result in a higher serum level.
Spirapril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Spirapril.
Spironolactone
Ibuprofen may decrease the antihypertensive activities of Spironolactone.
Streptomycin
Ibuprofen may decrease the excretion rate of Streptomycin which could result in a higher serum level.
Streptozocin
Ibuprofen may decrease the excretion rate of Streptozocin which could result in a higher serum level.
Sulfadiazine
The metabolism of Ibuprofen can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Ibuprofen can be decreased when combined with Sulfamethoxazole.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ibuprofen.
Sulfisoxazole
The metabolism of Ibuprofen can be decreased when combined with Sulfisoxazole.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Ibuprofen.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Ibuprofen.
Tacrolimus
Ibuprofen may increase the nephrotoxic activities of Tacrolimus.
Tafluprost
The therapeutic efficacy of Tafluprost can be decreased when used in combination with Ibuprofen.
Talinolol
Ibuprofen may decrease the antihypertensive activities of Talinolol.
Talniflumate
The risk or severity of adverse effects can be increased when Talniflumate is combined with Ibuprofen.
Tamoxifen
The metabolism of Ibuprofen can be decreased when combined with Tamoxifen.
Technetium Tc 99m Medronate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Technetium Tc-99m medronate.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Ibuprofen.
Temafloxacin
Ibuprofen may increase the neuroexcitatory activities of Temafloxacin.
Tenofovir Disoproxil
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tenofovir disoproxil.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Ibuprofen.
Teriflunomide
The metabolism of Ibuprofen can be decreased when combined with Teriflunomide.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tiaprofenic acid.
Ticagrelor
The metabolism of Ibuprofen can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Ibuprofen can be decreased when combined with Ticlopidine.
Tiludronate
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tiludronic acid.
Tiludronic Acid
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tiludronic acid.
Timolol
Ibuprofen may decrease the antihypertensive activities of Timolol.
Timolol Anhydrous
Ibuprofen may decrease the antihypertensive activities of Timolol.
Tixocortol
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tixocortol.
Tobramycin
Ibuprofen may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Tolbutamide
The metabolism of Ibuprofen can be decreased when combined with Tolbutamide.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tolfenamic Acid.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Ibuprofen.
Topiramate
The metabolism of Ibuprofen can be decreased when combined with Topiramate.
Torsemide
The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.
Trandolapril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Trandolapril.
Tranilast
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tranilast.
Tranylcypromine
The metabolism of Ibuprofen can be decreased when combined with Tranylcypromine.
Travoprost
The therapeutic efficacy of Travoprost can be decreased when used in combination with Ibuprofen.
Treprostinil
The risk or severity of adverse effects can be increased when Treprostinil is combined with Ibuprofen.
Triamcinolone
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Triamcinolone.
Triamterene
Ibuprofen may decrease the antihypertensive activities of Triamterene.
Trichlormethiazide
The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Ibuprofen.
Trimethoprim
The metabolism of Ibuprofen can be decreased when combined with Trimethoprim.
Trovafloxacin
Ibuprofen may increase the neuroexcitatory activities of Trovafloxacin.
Troxerutin
Ibuprofen may increase the anticoagulant activities of Troxerutin.
UNOPROSTONE
The therapeutic efficacy of Unoprostone can be decreased when used in combination with Ibuprofen.
Valdecoxib
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Valdecoxib.
Valproate
The metabolism of Ibuprofen can be decreased when combined with Valproic Acid.
Valproic Acid
The metabolism of Ibuprofen can be decreased when combined with Valproic Acid.
Valrubicin
Ibuprofen may decrease the excretion rate of Valrubicin which could result in a higher serum level.
Valsartan
The metabolism of Ibuprofen can be decreased when combined with Valsartan.
Vancomycin
The serum concentration of Vancomycin can be increased when it is combined with Ibuprofen.
Vemurafenib
The serum concentration of Ibuprofen can be increased when it is combined with Vemurafenib.
Voriconazole
The serum concentration of Ibuprofen can be increased when it is combined with Voriconazole.
Warfarin
Ibuprofen may increase the anticoagulant activities of Warfarin.
Zafirlukast
The metabolism of Ibuprofen can be decreased when combined with Zafirlukast.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Ibuprofen.
Zofenopril
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Zofenopril.
Zoledronic Acid
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Zoledronic acid.
Zoledronic Acid Anhydrous
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Zoledronic acid.
Zomepirac
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Zomepirac.
